Glucophage XR 1000 mg tablete s produljenim oslobađanjem
Name | Glucophage XR 1000 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-669077962 |
Active Substance | metforminklorid |
Composition | jedna tableta s produljenim oslobađanjem sadrži 1000 mg metforminklorida što odgovara 780 mg metformina |
Pharmaceutical Form | tableta s produljenim oslobađanjem |
Manufacturer | Merck Sante s.a.s., Semoy, Francuska Merck S.L., Barcelona, Španjolska Merck Healthcare KGaA, Darmstadt, Njemačka |
Marketing Authorisation Holder | Merck d.o.o., Oreškovićeva ulica 6H/1, Zagreb, Hrvatska |
Marketing Authorisation Date | 26.02.2024 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/23-02/101 |
Registration Number | 381-12-01/70-24-03 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | A10BA02 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |